Benjamin R. Yerxa - May 15, 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
May 15, 2024
Transactions value $
$10,235
Form type
4
Date filed
5/15/2024, 05:28 PM
Previous filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock +Buy $10,235 +7,813 +77.02% $1.31 17,957 May 15, 2024 Direct